CCL19 and asthma: Liu et al. showed that 10, 25, and 50 mg/kg baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-κB and suppressing CCR7/CCL19/CCL21 in comparison to dexamethasone (0.085 mg/kg) [56].